Chongqing Xishan Science & Technology Co., Ltd. (SHA:688576)
China · Delayed Price · Currency is CNY 40.50
-1.72 (-4.07%)
At close: Jul 13, 2026
SHA:688576 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 347.02 | 341.06 | 336.28 | 360.64 | 261.34 | 208.67 |
Other Revenue | 0.92 | 0.92 | 0.1 | 0.05 | 0.94 | 0.19 |
| 347.94 | 341.99 | 336.38 | 360.69 | 262.27 | 208.86 | |
Revenue Growth (YoY) | 6.06% | 1.67% | -6.74% | 37.52% | 25.57% | 63.97% |
Cost of Revenue | 137.64 | 131.77 | 102.95 | 113.35 | 83.25 | 63.39 |
Gross Profit | 210.3 | 210.22 | 233.43 | 247.34 | 179.02 | 145.47 |
Selling, General & Admin | 121.35 | 120.88 | 112.9 | 112.14 | 84.76 | 69.46 |
Research & Development | 59.03 | 58.08 | 55.24 | 46.5 | 29.94 | 28.09 |
Other Operating Expenses | 3.25 | 1.99 | -1.86 | -4.58 | 1.58 | -1.85 |
Operating Expenses | 187.71 | 184.22 | 168.09 | 156.96 | 116.32 | 95.72 |
Operating Income | 22.59 | 26 | 65.33 | 90.38 | 62.7 | 49.75 |
Interest Expense | - | - | -0.05 | -0.2 | -0.36 | -0.44 |
Interest & Investment Income | 17.33 | 17.2 | 27.69 | 17.69 | 6.43 | 1.81 |
Currency Exchange Gain (Loss) | -0.28 | -0.28 | 0.11 | 0.01 | 0.01 | -0.04 |
Other Non Operating Income (Expenses) | 0.19 | 0.41 | 0.18 | -0.18 | 0 | 0.27 |
EBT Excluding Unusual Items | 39.84 | 43.33 | 93.25 | 107.7 | 68.78 | 51.34 |
Gain (Loss) on Sale of Investments | 5.68 | 6.88 | 13.5 | 5.13 | - | - |
Gain (Loss) on Sale of Assets | -0.1 | -0.37 | 0.06 | -0.18 | -0.24 | 4.55 |
Asset Writedown | -1.47 | - | - | - | - | - |
Other Unusual Items | 3.2 | 3.24 | 4.55 | 14.41 | 6.15 | 4.95 |
Pretax Income | 47.15 | 53.09 | 111.37 | 127.06 | 74.69 | 60.84 |
Income Tax Expense | -0.57 | 1.18 | 12.7 | 9.71 | -0.66 | -0.59 |
Net Income | 47.72 | 51.91 | 98.67 | 117.34 | 75.35 | 61.43 |
Net Income to Common | 47.72 | 51.91 | 98.67 | 117.34 | 75.35 | 61.43 |
Net Income Growth | -43.36% | -47.39% | -15.92% | 55.73% | 22.66% | 332.89% |
Shares Outstanding (Basic) | 66 | 67 | 75 | 69 | 59 | 55 |
Shares Outstanding (Diluted) | 66 | 67 | 75 | 69 | 59 | 55 |
Shares Change (YoY) | -10.74% | -9.88% | 7.99% | 16.95% | 7.68% | 18.49% |
EPS (Basic) | 0.73 | 0.77 | 1.32 | 1.70 | 1.28 | 1.12 |
EPS (Diluted) | 0.73 | 0.77 | 1.32 | 1.70 | 1.28 | 1.12 |
EPS Growth | -36.55% | -41.62% | -22.14% | 33.16% | 13.92% | 265.34% |
Free Cash Flow | -20.72 | -35.96 | -118.08 | -35.64 | 29.95 | 41.7 |
Free Cash Flow Per Share | -0.32 | -0.54 | -1.58 | -0.52 | 0.51 | 0.76 |
Dividend Per Share | 0.336 | 0.336 | 0.671 | 0.671 | - | - |
Dividend Growth | -49.99% | -49.99% | - | - | - | - |
Gross Margin | 60.44% | 61.47% | 69.39% | 68.57% | 68.26% | 69.65% |
Operating Margin | 6.49% | 7.60% | 19.42% | 25.06% | 23.91% | 23.82% |
Profit Margin | 13.71% | 15.18% | 29.33% | 32.53% | 28.73% | 29.41% |
Free Cash Flow Margin | -5.96% | -10.51% | -35.10% | -9.88% | 11.42% | 19.96% |
EBITDA | 49.23 | 49.42 | 75.88 | 97.44 | 68.04 | 53.73 |
EBITDA Margin | 14.15% | 14.45% | 22.56% | 27.02% | 25.94% | 25.72% |
D&A For EBITDA | 26.64 | 23.42 | 10.55 | 7.06 | 5.34 | 3.98 |
EBIT | 22.59 | 26 | 65.33 | 90.38 | 62.7 | 49.75 |
EBIT Margin | 6.49% | 7.60% | 19.42% | 25.06% | 23.91% | 23.82% |
Effective Tax Rate | - | 2.22% | 11.40% | 7.65% | - | - |
Revenue as Reported | - | - | - | - | - | 208.86 |
Advertising Expenses | - | - | - | - | - | 5.85 |